Original article
Primary cardiac sarcomas

https://doi.org/10.1016/0003-4975(91)91003-EGet rights and content

Abstract

In marked contrast to benign cardiac tumors, primary cardiac sarcomas occur infrequently. Moreover, there is no uniform approach to treating such patients, and the benefits of postoperative chemotherapy are unclear. Between 1964 and 1989, 21 patients with primary cardiac sarcomas underwent surgical resection alone (n = 7), chemotherapy alone (n = 1), or combined operation and postoperative chemotherapy based on adriamycin (n = 13). Twenty-four operations were performed on 20 patients with relief of symptoms in all. Eleven patients had complete resection. Operative mortality was 8.3% (2/24). Histology and originating chamber(s) included angiosarcoma (n = 7; 6/7 in right atrium, 1 in left atrium), malignant fibrous histiocytoma (7; all in left atrium), fibrosarcoma (2; 2/2 in left atrium), rhabdomyosarcoma (2; 1 in left atrium, 1 in right ventricle), leiomyosarcoma (2; 1 in left atrium, 1 in left ventricle); and one undifferentiated sarcoma (right atrium). Overall actuarial survival was 14% at 24 months after resection. Patients with complete resection had a median survival of 24 months compared with only 10 months in all other patients (p = 0.035). Postoperative chemotherapy did not enhance survival in patients with incomplete resection. At this time, aggressive and complete surgical resection seems to offer the best hope for palliation and survival in an otherwise fatal disease.

References (24)

  • SW Jamieson et al.

    Operative treatment of an unresectable tumor of the left ventricle

    J Thorac Cardiovasc Surg

    (1981)
  • C Gabelman et al.

    Surgical treatment of recurrent primary malignant tumor of the left atrium

    J Thorac Cardiovasc Surg

    (1979)
  • Cited by (276)

    View all citing articles on Scopus

    Presented at the Thirty-seventh Annual Meeting of the Southern Thoracic Surgical Association, Dorado, Puerto Rico, Nov 8–10, 1990.

    View full text